<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>PuSH - HMGU Publikationen</title>
    <link>https://push-zb.helmholtz-munich.de</link>
    <description>
    PuSH - Publikationen-Server des Helmholtz Zentrums München
    </description>
    <language>de-de</language>

    <item>
      <title><![CDATA[Tirado, N.* et al. CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia. J. Hematol. Oncol. 18:69 (2025)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=75054&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=75054&amp;la=de</guid>
      <pubDate>Wed, 16 Jul 2025 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Hallermayr, A.* et al. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients. J. Hematol. Oncol. 15:125 (2022)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=66086&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=66086&amp;la=de</guid>
      <pubDate>Tue, 20 Sep 2022 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Zeller, C. et al. Adverse stem cell clones within a single patient’s tumor predict clinical outcome in AML patients. J. Hematol. Oncol. 15:25 (2022)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=64605&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=64605&amp;la=de</guid>
      <pubDate>Thu, 28 Apr 2022 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Tahk, S.* et al. SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells. J. Hematol. Oncol. 14:155 (2021)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=63101&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=63101&amp;la=de</guid>
      <pubDate>Tue, 02 Nov 2021 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Köhnke, T. ; Krupka, C. ; Tischer, J. ; Knösel, T.* &amp; Subklewe, M. Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab. J. Hematol. Oncol. 8:111 (2015)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47087&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47087&amp;la=de</guid>
      <pubDate>Fri, 16 Oct 2015 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Schnorfeil, F.M. et al. T cells are functionally not impaired in AML: Increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J. Hematol. Oncol. 9:93 (2015)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47092&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47092&amp;la=de</guid>
      <pubDate>Fri, 16 Oct 2015 00:00:00 +0000</pubDate>
    </item>
    </channel>
</rss>